nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR7—Parkinson's disease	0.156	0.209	CbGaD
Cabergoline—DRD3—Parkinson's disease	0.147	0.197	CbGaD
Cabergoline—DRD1—Parkinson's disease	0.144	0.193	CbGaD
Cabergoline—HTR1A—Parkinson's disease	0.12	0.16	CbGaD
Cabergoline—DRD2—Parkinson's disease	0.102	0.136	CbGaD
Cabergoline—HTR2A—Parkinson's disease	0.0785	0.105	CbGaD
Cabergoline—HTR7—enteric nervous system—Parkinson's disease	0.00464	0.0476	CbGeAlD
Cabergoline—HTR7—superior cervical ganglion—Parkinson's disease	0.00444	0.0455	CbGeAlD
Cabergoline—HTR7—myenteric nerve plexus—Parkinson's disease	0.00352	0.0361	CbGeAlD
Cabergoline—DRD3—telencephalic ventricle—Parkinson's disease	0.00325	0.0333	CbGeAlD
Cabergoline—HTR7—locus ceruleus—Parkinson's disease	0.00307	0.0314	CbGeAlD
Cabergoline—HTR2A—enteric nervous system—Parkinson's disease	0.0029	0.0297	CbGeAlD
Cabergoline—HTR7—sympathetic nervous system—Parkinson's disease	0.00242	0.0248	CbGeAlD
Cabergoline—DRD1—telencephalic ventricle—Parkinson's disease	0.00233	0.0238	CbGeAlD
Cabergoline—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00219	0.0225	CbGeAlD
Cabergoline—HTR2A—locus ceruleus—Parkinson's disease	0.00191	0.0196	CbGeAlD
Cabergoline—HTR1B—telencephalic ventricle—Parkinson's disease	0.00188	0.0193	CbGeAlD
Cabergoline—HTR1D—telencephalic ventricle—Parkinson's disease	0.00182	0.0187	CbGeAlD
Cabergoline—HTR2C—telencephalic ventricle—Parkinson's disease	0.00181	0.0185	CbGeAlD
Cabergoline—HTR7—pons—Parkinson's disease	0.00177	0.0181	CbGeAlD
Cabergoline—HTR7—autonomic nervous system—Parkinson's disease	0.00163	0.0167	CbGeAlD
Cabergoline—HTR2A—cerebellar cortex—Parkinson's disease	0.00156	0.016	CbGeAlD
Cabergoline—HTR1A—telencephalic ventricle—Parkinson's disease	0.00152	0.0156	CbGeAlD
Cabergoline—HTR2A—sympathetic nervous system—Parkinson's disease	0.00151	0.0155	CbGeAlD
Cabergoline—DRD1—nerve—Parkinson's disease	0.00147	0.015	CbGeAlD
Cabergoline—HTR7—telencephalic ventricle—Parkinson's disease	0.00145	0.0149	CbGeAlD
Cabergoline—DRD2—telencephalic ventricle—Parkinson's disease	0.00137	0.0141	CbGeAlD
Cabergoline—HTR7—peripheral nervous system—Parkinson's disease	0.00118	0.012	CbGeAlD
Cabergoline—HTR2A—pons—Parkinson's disease	0.0011	0.0113	CbGeAlD
Cabergoline—HTR2A—autonomic nervous system—Parkinson's disease	0.00102	0.0104	CbGeAlD
Cabergoline—HTR7—nerve—Parkinson's disease	0.000916	0.00939	CbGeAlD
Cabergoline—HTR2A—telencephalic ventricle—Parkinson's disease	0.000906	0.00929	CbGeAlD
Cabergoline—DRD2—nerve—Parkinson's disease	0.000866	0.00888	CbGeAlD
Cabergoline—ADRA2A—peripheral nervous system—Parkinson's disease	0.000862	0.00883	CbGeAlD
Cabergoline—DRD5—forebrain—Parkinson's disease	0.000795	0.00815	CbGeAlD
Cabergoline—HTR2A—peripheral nervous system—Parkinson's disease	0.000733	0.00751	CbGeAlD
Cabergoline—Pergolide—DRD3—Parkinson's disease	0.000727	0.119	CrCbGaD
Cabergoline—HTR1A—hindbrain—Parkinson's disease	0.000718	0.00736	CbGeAlD
Cabergoline—Pergolide—DRD1—Parkinson's disease	0.000714	0.116	CrCbGaD
Cabergoline—HTR7—hindbrain—Parkinson's disease	0.000686	0.00703	CbGeAlD
Cabergoline—ADRA1A—hindbrain—Parkinson's disease	0.000662	0.00678	CbGeAlD
Cabergoline—DRD2—hindbrain—Parkinson's disease	0.000649	0.00665	CbGeAlD
Cabergoline—ADRA1D—forebrain—Parkinson's disease	0.000637	0.00653	CbGeAlD
Cabergoline—Lisuride—DRD3—Parkinson's disease	0.000631	0.103	CrCbGaD
Cabergoline—DRD1—brainstem—Parkinson's disease	0.000629	0.00645	CbGeAlD
Cabergoline—Lisuride—DRD1—Parkinson's disease	0.00062	0.101	CrCbGaD
Cabergoline—DRD1—forebrain—Parkinson's disease	0.000607	0.00622	CbGeAlD
Cabergoline—Pergolide—HTR1A—Parkinson's disease	0.000593	0.0967	CrCbGaD
Cabergoline—HTR2A—nerve—Parkinson's disease	0.000571	0.00585	CbGeAlD
Cabergoline—Lisuride—HTR1A—Parkinson's disease	0.000515	0.0839	CrCbGaD
Cabergoline—HTR1B—brainstem—Parkinson's disease	0.00051	0.00523	CbGeAlD
Cabergoline—Pergolide—DRD2—Parkinson's disease	0.000503	0.0821	CrCbGaD
Cabergoline—DRD4—brain—Parkinson's disease	0.000501	0.00513	CbGeAlD
Cabergoline—HTR1D—brainstem—Parkinson's disease	0.000494	0.00506	CbGeAlD
Cabergoline—HTR1B—forebrain—Parkinson's disease	0.000492	0.00504	CbGeAlD
Cabergoline—HTR2C—brainstem—Parkinson's disease	0.000489	0.00501	CbGeAlD
Cabergoline—DRD3—head—Parkinson's disease	0.000486	0.00498	CbGeAlD
Cabergoline—HTR1D—forebrain—Parkinson's disease	0.000477	0.00488	CbGeAlD
Cabergoline—HTR2C—forebrain—Parkinson's disease	0.000472	0.00484	CbGeAlD
Cabergoline—ADRB1—forebrain—Parkinson's disease	0.000463	0.00474	CbGeAlD
Cabergoline—DRD3—nervous system—Parkinson's disease	0.000461	0.00472	CbGeAlD
Cabergoline—DRD5—head—Parkinson's disease	0.000455	0.00466	CbGeAlD
Cabergoline—DRD3—central nervous system—Parkinson's disease	0.000443	0.00454	CbGeAlD
Cabergoline—HTR2B—forebrain—Parkinson's disease	0.000443	0.00454	CbGeAlD
Cabergoline—Lisuride—DRD2—Parkinson's disease	0.000437	0.0712	CrCbGaD
Cabergoline—DRD5—nervous system—Parkinson's disease	0.000432	0.00442	CbGeAlD
Cabergoline—HTR2A—hindbrain—Parkinson's disease	0.000428	0.00438	CbGeAlD
Cabergoline—HTR1B—cardiovascular system—Parkinson's disease	0.000416	0.00426	CbGeAlD
Cabergoline—DRD5—central nervous system—Parkinson's disease	0.000416	0.00426	CbGeAlD
Cabergoline—HTR1A—brainstem—Parkinson's disease	0.000412	0.00422	CbGeAlD
Cabergoline—HTR1D—cardiovascular system—Parkinson's disease	0.000403	0.00413	CbGeAlD
Cabergoline—DRD1—midbrain—Parkinson's disease	0.000401	0.00411	CbGeAlD
Cabergoline—HTR1A—forebrain—Parkinson's disease	0.000397	0.00407	CbGeAlD
Cabergoline—HTR7—brainstem—Parkinson's disease	0.000393	0.00403	CbGeAlD
Cabergoline—ADRB1—cardiovascular system—Parkinson's disease	0.000392	0.00401	CbGeAlD
Cabergoline—Pergolide—HTR2A—Parkinson's disease	0.000389	0.0634	CrCbGaD
Cabergoline—HTR7—forebrain—Parkinson's disease	0.00038	0.00389	CbGeAlD
Cabergoline—ADRA1A—brainstem—Parkinson's disease	0.000379	0.00389	CbGeAlD
Cabergoline—HTR2B—cardiovascular system—Parkinson's disease	0.000375	0.00384	CbGeAlD
Cabergoline—ADRA1B—head—Parkinson's disease	0.000373	0.00382	CbGeAlD
Cabergoline—DRD2—brainstem—Parkinson's disease	0.000372	0.00381	CbGeAlD
Cabergoline—ADRA1A—forebrain—Parkinson's disease	0.000366	0.00375	CbGeAlD
Cabergoline—ADRA1D—head—Parkinson's disease	0.000365	0.00374	CbGeAlD
Cabergoline—DRD2—forebrain—Parkinson's disease	0.000359	0.00368	CbGeAlD
Cabergoline—Pergolide—CYP2D6—Parkinson's disease	0.000356	0.058	CrCbGaD
Cabergoline—ADRA1B—nervous system—Parkinson's disease	0.000354	0.00363	CbGeAlD
Cabergoline—DRD3—brain—Parkinson's disease	0.000352	0.00361	CbGeAlD
Cabergoline—DRD1—head—Parkinson's disease	0.000348	0.00356	CbGeAlD
Cabergoline—ADRA1D—nervous system—Parkinson's disease	0.000346	0.00355	CbGeAlD
Cabergoline—HTR2C—medulla oblongata—Parkinson's disease	0.000341	0.00349	CbGeAlD
Cabergoline—ADRA1B—central nervous system—Parkinson's disease	0.000341	0.00349	CbGeAlD
Cabergoline—Lisuride—HTR2A—Parkinson's disease	0.000338	0.055	CrCbGaD
Cabergoline—HTR1A—cardiovascular system—Parkinson's disease	0.000336	0.00344	CbGeAlD
Cabergoline—ADRA1D—central nervous system—Parkinson's disease	0.000333	0.00341	CbGeAlD
Cabergoline—DRD5—brain—Parkinson's disease	0.00033	0.00338	CbGeAlD
Cabergoline—DRD1—nervous system—Parkinson's disease	0.00033	0.00338	CbGeAlD
Cabergoline—HTR1B—midbrain—Parkinson's disease	0.000325	0.00333	CbGeAlD
Cabergoline—HTR7—cardiovascular system—Parkinson's disease	0.000321	0.00329	CbGeAlD
Cabergoline—DRD1—central nervous system—Parkinson's disease	0.000317	0.00325	CbGeAlD
Cabergoline—HTR1B—spinal cord—Parkinson's disease	0.000317	0.00325	CbGeAlD
Cabergoline—HTR1D—midbrain—Parkinson's disease	0.000315	0.00322	CbGeAlD
Cabergoline—HTR2C—midbrain—Parkinson's disease	0.000312	0.00319	CbGeAlD
Cabergoline—ADRA1A—cardiovascular system—Parkinson's disease	0.00031	0.00317	CbGeAlD
Cabergoline—Lisuride—CYP2D6—Parkinson's disease	0.000309	0.0503	CrCbGaD
Cabergoline—HTR2C—spinal cord—Parkinson's disease	0.000304	0.00312	CbGeAlD
Cabergoline—HTR1B—head—Parkinson's disease	0.000282	0.00289	CbGeAlD
Cabergoline—ADRA2A—forebrain—Parkinson's disease	0.000278	0.00285	CbGeAlD
Cabergoline—HTR7—medulla oblongata—Parkinson's disease	0.000274	0.00281	CbGeAlD
Cabergoline—HTR1D—head—Parkinson's disease	0.000273	0.0028	CbGeAlD
Cabergoline—ADRA1B—brain—Parkinson's disease	0.00027	0.00277	CbGeAlD
Cabergoline—HTR2C—head—Parkinson's disease	0.00027	0.00277	CbGeAlD
Cabergoline—HTR2A—embryo—Parkinson's disease	0.000268	0.00274	CbGeAlD
Cabergoline—HTR1B—nervous system—Parkinson's disease	0.000267	0.00274	CbGeAlD
Cabergoline—ADRB1—head—Parkinson's disease	0.000265	0.00272	CbGeAlD
Cabergoline—ADRA1D—brain—Parkinson's disease	0.000265	0.00271	CbGeAlD
Cabergoline—HTR1A—midbrain—Parkinson's disease	0.000262	0.00269	CbGeAlD
Cabergoline—HTR1D—nervous system—Parkinson's disease	0.000259	0.00265	CbGeAlD
Cabergoline—HTR1B—central nervous system—Parkinson's disease	0.000257	0.00264	CbGeAlD
Cabergoline—HTR2C—nervous system—Parkinson's disease	0.000256	0.00262	CbGeAlD
Cabergoline—HTR1A—spinal cord—Parkinson's disease	0.000256	0.00262	CbGeAlD
Cabergoline—HTR2B—head—Parkinson's disease	0.000254	0.0026	CbGeAlD
Cabergoline—ADRA2C—medulla oblongata—Parkinson's disease	0.000252	0.00258	CbGeAlD
Cabergoline—DRD1—brain—Parkinson's disease	0.000252	0.00258	CbGeAlD
Cabergoline—ADRB1—nervous system—Parkinson's disease	0.000251	0.00258	CbGeAlD
Cabergoline—HTR7—midbrain—Parkinson's disease	0.000251	0.00257	CbGeAlD
Cabergoline—HTR1D—central nervous system—Parkinson's disease	0.000249	0.00255	CbGeAlD
Cabergoline—HTR2C—central nervous system—Parkinson's disease	0.000247	0.00253	CbGeAlD
Cabergoline—HTR2A—brainstem—Parkinson's disease	0.000245	0.00251	CbGeAlD
Cabergoline—HTR7—spinal cord—Parkinson's disease	0.000245	0.00251	CbGeAlD
Cabergoline—ADRB1—central nervous system—Parkinson's disease	0.000242	0.00248	CbGeAlD
Cabergoline—HTR2B—nervous system—Parkinson's disease	0.000241	0.00247	CbGeAlD
Cabergoline—DRD2—midbrain—Parkinson's disease	0.000237	0.00243	CbGeAlD
Cabergoline—HTR2A—forebrain—Parkinson's disease	0.000237	0.00243	CbGeAlD
Cabergoline—HTR2B—central nervous system—Parkinson's disease	0.000232	0.00237	CbGeAlD
Cabergoline—ADRA2C—midbrain—Parkinson's disease	0.00023	0.00236	CbGeAlD
Cabergoline—HTR1A—head—Parkinson's disease	0.000227	0.00233	CbGeAlD
Cabergoline—ADRA2C—spinal cord—Parkinson's disease	0.000225	0.0023	CbGeAlD
Cabergoline—HTR7—head—Parkinson's disease	0.000217	0.00223	CbGeAlD
Cabergoline—HTR1A—nervous system—Parkinson's disease	0.000216	0.00221	CbGeAlD
Cabergoline—ADRA1A—head—Parkinson's disease	0.00021	0.00215	CbGeAlD
Cabergoline—HTR1A—central nervous system—Parkinson's disease	0.000208	0.00213	CbGeAlD
Cabergoline—HTR7—nervous system—Parkinson's disease	0.000206	0.00211	CbGeAlD
Cabergoline—DRD2—head—Parkinson's disease	0.000205	0.00211	CbGeAlD
Cabergoline—HTR1B—brain—Parkinson's disease	0.000204	0.00209	CbGeAlD
Cabergoline—HTR1A—cerebellum—Parkinson's disease	0.000203	0.00208	CbGeAlD
Cabergoline—ADRA2A—medulla oblongata—Parkinson's disease	0.000201	0.00206	CbGeAlD
Cabergoline—HTR2A—cardiovascular system—Parkinson's disease	0.0002	0.00205	CbGeAlD
Cabergoline—ADRA2C—head—Parkinson's disease	0.0002	0.00205	CbGeAlD
Cabergoline—ADRA1A—nervous system—Parkinson's disease	0.000199	0.00204	CbGeAlD
Cabergoline—HTR7—central nervous system—Parkinson's disease	0.000198	0.00203	CbGeAlD
Cabergoline—HTR1D—brain—Parkinson's disease	0.000198	0.00203	CbGeAlD
Cabergoline—HTR2C—brain—Parkinson's disease	0.000196	0.00201	CbGeAlD
Cabergoline—DRD2—nervous system—Parkinson's disease	0.000195	0.002	CbGeAlD
Cabergoline—HTR7—cerebellum—Parkinson's disease	0.000194	0.00199	CbGeAlD
Cabergoline—ADRB1—brain—Parkinson's disease	0.000192	0.00197	CbGeAlD
Cabergoline—ADRA1A—central nervous system—Parkinson's disease	0.000191	0.00196	CbGeAlD
Cabergoline—ADRA2C—nervous system—Parkinson's disease	0.000189	0.00194	CbGeAlD
Cabergoline—DRD2—central nervous system—Parkinson's disease	0.000188	0.00192	CbGeAlD
Cabergoline—ADRA1A—cerebellum—Parkinson's disease	0.000187	0.00192	CbGeAlD
Cabergoline—HTR2B—brain—Parkinson's disease	0.000184	0.00188	CbGeAlD
Cabergoline—ADRA2A—midbrain—Parkinson's disease	0.000184	0.00188	CbGeAlD
Cabergoline—DRD2—cerebellum—Parkinson's disease	0.000183	0.00188	CbGeAlD
Cabergoline—ADRA2C—central nervous system—Parkinson's disease	0.000182	0.00187	CbGeAlD
Cabergoline—ADRA2A—spinal cord—Parkinson's disease	0.000179	0.00184	CbGeAlD
Cabergoline—ADRA2C—cerebellum—Parkinson's disease	0.000178	0.00183	CbGeAlD
Cabergoline—HTR2A—medulla oblongata—Parkinson's disease	0.000171	0.00175	CbGeAlD
Cabergoline—HTR1A—brain—Parkinson's disease	0.000165	0.00169	CbGeAlD
Cabergoline—ADRA2A—head—Parkinson's disease	0.000159	0.00163	CbGeAlD
Cabergoline—HTR7—brain—Parkinson's disease	0.000158	0.00161	CbGeAlD
Cabergoline—HTR2A—midbrain—Parkinson's disease	0.000156	0.0016	CbGeAlD
Cabergoline—HTR2A—spinal cord—Parkinson's disease	0.000153	0.00156	CbGeAlD
Cabergoline—ADRA1A—brain—Parkinson's disease	0.000152	0.00156	CbGeAlD
Cabergoline—ADRA2A—nervous system—Parkinson's disease	0.000151	0.00155	CbGeAlD
Cabergoline—DRD2—brain—Parkinson's disease	0.000149	0.00153	CbGeAlD
Cabergoline—ADRA2A—central nervous system—Parkinson's disease	0.000146	0.00149	CbGeAlD
Cabergoline—ADRA2C—brain—Parkinson's disease	0.000145	0.00148	CbGeAlD
Cabergoline—ADRA2A—cerebellum—Parkinson's disease	0.000142	0.00146	CbGeAlD
Cabergoline—HTR2A—head—Parkinson's disease	0.000136	0.00139	CbGeAlD
Cabergoline—HTR2A—nervous system—Parkinson's disease	0.000129	0.00132	CbGeAlD
Cabergoline—HTR2A—central nervous system—Parkinson's disease	0.000124	0.00127	CbGeAlD
Cabergoline—HTR2A—cerebellum—Parkinson's disease	0.000121	0.00124	CbGeAlD
Cabergoline—CYP3A4—nervous system—Parkinson's disease	0.000119	0.00122	CbGeAlD
Cabergoline—ADRA2A—brain—Parkinson's disease	0.000116	0.00118	CbGeAlD
Cabergoline—CYP3A4—central nervous system—Parkinson's disease	0.000115	0.00117	CbGeAlD
Cabergoline—HTR2A—brain—Parkinson's disease	9.82e-05	0.00101	CbGeAlD
Cabergoline—ADRA2A—Metabolism—TH—Parkinson's disease	6.57e-06	4.4e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	6.56e-06	4.4e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	6.54e-06	4.39e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	6.54e-06	4.39e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—NGF—Parkinson's disease	6.53e-06	4.38e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—HTR2A—Parkinson's disease	6.49e-06	4.35e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—ABCB1—Parkinson's disease	6.48e-06	4.34e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	6.47e-06	4.34e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	6.45e-06	4.32e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	6.43e-06	4.31e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	6.42e-06	4.3e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	6.4e-06	4.29e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—EDN1—Parkinson's disease	6.4e-06	4.29e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	6.39e-06	4.28e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	6.39e-06	4.28e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	6.38e-06	4.28e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	6.32e-06	4.23e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—EDN1—Parkinson's disease	6.31e-06	4.23e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	6.31e-06	4.23e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—CYCS—Parkinson's disease	6.31e-06	4.23e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—GSTM1—Parkinson's disease	6.29e-06	4.22e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	6.29e-06	4.21e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—NGF—Parkinson's disease	6.23e-06	4.18e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	6.23e-06	4.17e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—HTR2A—Parkinson's disease	6.22e-06	4.17e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	6.17e-06	4.13e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	6.13e-06	4.11e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—APOE—Parkinson's disease	6.04e-06	4.05e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HTR7—Parkinson's disease	6.03e-06	4.04e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—GPX1—Parkinson's disease	6.03e-06	4.04e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	6.02e-06	4.03e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	6e-06	4.02e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—APOE—Parkinson's disease	6e-06	4.02e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	5.97e-06	4e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IGF2—Parkinson's disease	5.97e-06	4e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	5.94e-06	3.98e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	5.94e-06	3.98e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	5.93e-06	3.98e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	5.89e-06	3.95e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—NGF—Parkinson's disease	5.88e-06	3.94e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—APOE—Parkinson's disease	5.87e-06	3.94e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	5.82e-06	3.9e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	5.81e-06	3.9e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	5.81e-06	3.9e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—NGF—Parkinson's disease	5.8e-06	3.89e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	5.8e-06	3.89e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—APOE—Parkinson's disease	5.78e-06	3.87e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IGF1R—Parkinson's disease	5.77e-06	3.86e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	5.76e-06	3.86e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	5.75e-06	3.85e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	5.73e-06	3.84e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—EDN1—Parkinson's disease	5.7e-06	3.82e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	5.69e-06	3.82e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	5.63e-06	3.77e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	5.6e-06	3.75e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—COMT—Parkinson's disease	5.59e-06	3.74e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	5.58e-06	3.74e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IGF2—Parkinson's disease	5.57e-06	3.73e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	5.57e-06	3.73e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GSTP1—Parkinson's disease	5.56e-06	3.73e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—MTHFR—Parkinson's disease	5.56e-06	3.73e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—MAOA—Parkinson's disease	5.55e-06	3.72e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	5.54e-06	3.71e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	5.52e-06	3.7e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	5.52e-06	3.7e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—APOE—Parkinson's disease	5.52e-06	3.7e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	5.5e-06	3.69e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—HMOX1—Parkinson's disease	5.49e-06	3.68e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	5.48e-06	3.67e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	5.47e-06	3.67e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	5.4e-06	3.62e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	5.4e-06	3.62e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IGF1R—Parkinson's disease	5.39e-06	3.61e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—EDN1—Parkinson's disease	5.32e-06	3.57e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	5.3e-06	3.55e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NGF—Parkinson's disease	5.29e-06	3.54e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—ABCB1—Parkinson's disease	5.27e-06	3.53e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	5.24e-06	3.51e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NGF—Parkinson's disease	5.24e-06	3.51e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—APOE—Parkinson's disease	5.2e-06	3.49e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—APOE—Parkinson's disease	5.18e-06	3.47e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NGF—Parkinson's disease	5.17e-06	3.46e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—INS—Parkinson's disease	5.16e-06	3.46e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—APOE—Parkinson's disease	5.13e-06	3.44e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	5.13e-06	3.44e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—INS—Parkinson's disease	5.12e-06	3.43e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GSTM1—Parkinson's disease	5.11e-06	3.43e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF2—Parkinson's disease	5.06e-06	3.39e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NGF—Parkinson's disease	5.06e-06	3.39e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	5.03e-06	3.37e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NGF—Parkinson's disease	5.03e-06	3.37e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—DDC—Parkinson's disease	5.02e-06	3.37e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—INS—Parkinson's disease	5.02e-06	3.36e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	4.99e-06	3.34e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CASP3—Parkinson's disease	4.98e-06	3.34e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	4.97e-06	3.33e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—IL6—Parkinson's disease	4.95e-06	3.32e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—INS—Parkinson's disease	4.94e-06	3.31e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	4.92e-06	3.3e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—GPX1—Parkinson's disease	4.9e-06	3.28e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	4.89e-06	3.28e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	4.89e-06	3.28e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	4.87e-06	3.26e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—EDN1—Parkinson's disease	4.83e-06	3.24e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	4.81e-06	3.23e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	4.81e-06	3.22e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	4.81e-06	3.22e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	4.79e-06	3.21e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	4.75e-06	3.18e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTA4—Parkinson's disease	4.74e-06	3.18e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—INS—Parkinson's disease	4.71e-06	3.16e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	4.71e-06	3.16e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—APOE—Parkinson's disease	4.68e-06	3.13e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	4.66e-06	3.12e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	4.65e-06	3.12e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	4.64e-06	3.11e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	4.58e-06	3.07e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—MAPK8—Parkinson's disease	4.58e-06	3.07e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—APOE—Parkinson's disease	4.58e-06	3.07e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	4.53e-06	3.03e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—MTHFR—Parkinson's disease	4.52e-06	3.03e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—APOE—Parkinson's disease	4.47e-06	3e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—APOE—Parkinson's disease	4.45e-06	2.98e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—INS—Parkinson's disease	4.45e-06	2.98e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NGF—Parkinson's disease	4.44e-06	2.97e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—INS—Parkinson's disease	4.42e-06	2.96e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—INS—Parkinson's disease	4.39e-06	2.94e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—INS—Parkinson's disease	4.39e-06	2.94e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	4.38e-06	2.93e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NGF—Parkinson's disease	4.37e-06	2.93e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	4.33e-06	2.9e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	4.32e-06	2.9e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	4.28e-06	2.87e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.27e-06	2.86e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	4.26e-06	2.86e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.23e-06	2.83e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	4.23e-06	2.83e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—APOE—Parkinson's disease	4.21e-06	2.82e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	4.07e-06	2.73e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—INS—Parkinson's disease	4e-06	2.68e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	3.97e-06	2.66e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—INS—Parkinson's disease	3.96e-06	2.65e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—APOE—Parkinson's disease	3.93e-06	2.63e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—INS—Parkinson's disease	3.91e-06	2.62e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—APOE—Parkinson's disease	3.87e-06	2.59e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CASP3—Parkinson's disease	3.84e-06	2.57e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—INS—Parkinson's disease	3.82e-06	2.56e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—IL6—Parkinson's disease	3.82e-06	2.56e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	3.82e-06	2.56e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—INS—Parkinson's disease	3.8e-06	2.55e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	3.79e-06	2.54e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	3.78e-06	2.54e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	3.78e-06	2.53e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	3.74e-06	2.5e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	3.71e-06	2.49e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—INS—Parkinson's disease	3.7e-06	2.48e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CASP3—Parkinson's disease	3.68e-06	2.46e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—IL6—Parkinson's disease	3.65e-06	2.45e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—INS—Parkinson's disease	3.64e-06	2.44e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—INS—Parkinson's disease	3.59e-06	2.41e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	3.53e-06	2.37e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	3.52e-06	2.36e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	3.51e-06	2.35e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	3.51e-06	2.35e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	3.49e-06	2.34e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	3.43e-06	2.3e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	3.38e-06	2.26e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—INS—Parkinson's disease	3.36e-06	2.25e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CASP3—Parkinson's disease	3.31e-06	2.22e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—INS—Parkinson's disease	3.3e-06	2.21e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL6—Parkinson's disease	3.29e-06	2.2e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CASP3—Parkinson's disease	3.27e-06	2.19e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	3.27e-06	2.19e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL6—Parkinson's disease	3.24e-06	2.17e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	3.24e-06	2.17e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—INS—Parkinson's disease	3.23e-06	2.17e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	3.23e-06	2.16e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.14e-06	2.11e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.08e-06	2.07e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	3.04e-06	2.04e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—INS—Parkinson's disease	3e-06	2.01e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	3e-06	2.01e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	3e-06	2.01e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	2.98e-06	1.99e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	2.96e-06	1.98e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	2.95e-06	1.98e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	2.93e-06	1.96e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—Parkinson's disease	2.92e-06	1.96e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	2.91e-06	1.95e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	2.89e-06	1.94e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.87e-06	1.93e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.85e-06	1.91e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.84e-06	1.9e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.83e-06	1.9e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.83e-06	1.89e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.81e-06	1.88e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—TH—Parkinson's disease	2.8e-06	1.88e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	2.75e-06	1.85e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	2.74e-06	1.83e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	2.73e-06	1.83e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	2.71e-06	1.82e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	2.71e-06	1.82e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	2.69e-06	1.8e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.69e-06	1.8e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	2.67e-06	1.79e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	2.62e-06	1.75e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.6e-06	1.74e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	2.53e-06	1.7e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.5e-06	1.67e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	2.49e-06	1.67e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.48e-06	1.66e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.46e-06	1.65e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.44e-06	1.64e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	2.41e-06	1.61e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	2.39e-06	1.6e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—COMT—Parkinson's disease	2.38e-06	1.6e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.37e-06	1.59e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.36e-06	1.58e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.34e-06	1.57e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.3e-06	1.54e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.26e-06	1.51e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—Parkinson's disease	2.25e-06	1.51e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.24e-06	1.5e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—Parkinson's disease	2.24e-06	1.5e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.24e-06	1.5e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.22e-06	1.49e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.21e-06	1.48e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—Parkinson's disease	2.19e-06	1.47e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.18e-06	1.46e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—Parkinson's disease	2.16e-06	1.45e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.09e-06	1.4e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—Parkinson's disease	2.06e-06	1.38e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.06e-06	1.38e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—Parkinson's disease	1.94e-06	1.3e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.92e-06	1.29e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.92e-06	1.28e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	1.92e-06	1.28e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—Parkinson's disease	1.79e-06	1.2e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.75e-06	1.17e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.73e-06	1.16e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—Parkinson's disease	1.71e-06	1.14e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.67e-06	1.12e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.66e-06	1.11e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.62e-06	1.08e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.59e-06	1.07e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—INS—Parkinson's disease	1.53e-06	1.03e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.47e-06	9.83e-06	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.44e-06	9.67e-06	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.41e-06	9.47e-06	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	8.8e-06	CbGpPWpGaD
